Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

GDC-0214

Copy Product Info
🥰Excellent
Catalog No. T9826Cas No. 1831144-46-7

GDC-0214 is an inhaled small-molecule JAK1 inhibitor and reduces fractional exhaled nitric oxide (Feno).

GDC-0214

GDC-0214

Copy Product Info
🥰Excellent
Purity: 99.75%
Catalog No. T9826Cas No. 1831144-46-7
GDC-0214 is an inhaled small-molecule JAK1 inhibitor and reduces fractional exhaled nitric oxide (Feno).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$89In StockIn Stock
5 mg$202In StockIn Stock
10 mg$298In StockIn Stock
25 mg$476In StockIn Stock
50 mg$678In StockIn Stock
100 mg$912In StockIn Stock
200 mg$1,220In StockIn Stock
1 mL x 10 mM (in DMSO)$273In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.75%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

GDC-0214 AI Summary
GDC-0214 shows potent inhibitory activity against JAK enzymes, specifically JAK1 and JAK2 kinase domains. The compound effectively blocks the phosphorylation of a peptide substrate derived from JAK3, as demonstrated by low inhibition constants (Ki) of 0.34 nM and 0.7 nM. This suggests that GDC-0214 has the potential to modulate JAK signaling pathways, which are involved in various cellular processes and have implications in inflammatory and autoimmune diseases. Additionally, GDC-0214 has a solubility of 34000.0 nM at pH 7.4 and an apparent permeability from apical to basolateral side in MDCK cells of 2.7 x 10^-6 cm/s..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
GDC-0214 is an inhaled small-molecule JAK1 inhibitor and reduces fractional exhaled nitric oxide (Feno).
Chemical Properties
Molecular Weight612.03
FormulaC28H28ClF2N9O3
Cas No.1831144-46-7
SmilesN(C(=O)C1=C2N(N=C1)C=CC=N2)C=3C(=NN(CC(=O)N4CCC(N(CCC#N)C)CC4)C3)C5=C(OC(F)F)C=CC(Cl)=C5
Relative Density.1.47 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 9 mg/mL (14.71 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.6339 mL8.1695 mL16.3391 mL81.6953 mL
5 mM0.3268 mL1.6339 mL3.2678 mL16.3391 mL
10 mM0.1634 mL0.8170 mL1.6339 mL8.1695 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GDC-0214 | purchase GDC-0214 | GDC-0214 cost | order GDC-0214 | GDC-0214 chemical structure | GDC-0214 formula | GDC-0214 molecular weight